Alberta Investment Management Corp (AIMCo)’s PDL BioPharma, Inc. PDLI Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-55,500	Closed	-$174K	–	1076
2019 Q2	$174K	Buy	+55,500	New	+$180K	﹤0.01%	879
2017 Q4	–	Sell	-153,600	Closed	-$521K	–	867
2017 Q3	$521K	Hold	153,600	–	–	﹤0.01%	647
2017 Q2	$379K	Sell	153,600 -46,800	-23%	-$108K	﹤0.01%	668
2017 Q1	$455K	Buy	+200,400	New	+$443K	﹤0.01%	700
2016 Q4	–	Sell	-182,200	Closed	-$610K	–	875
2016 Q3	$610K	Buy	+182,200	New	+$578K	0.01%	590

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Alberta Investment Management Corp (AIMCo)'s PDLI Position: Q3 2019 in Review

Alberta Investment Management Corp (AIMCo) sold out of PDL BioPharma, Inc. (PDLI) in Q3 2019, closing a stake of 55,500 shares — an estimated $174K sold.

Alberta Investment Management Corp (AIMCo) first reported a position in PDLI in Q3 2016 and held it in 5 quarters. The position peaked at $610K in Q3 2016. 140 funds tracked by Wall St. Rank hold PDLI as of Q3 2019.

Alberta Investment Management Corp (AIMCo) reported no remaining PDL BioPharma, Inc. position as of Q3 2019 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 55,500 PDL BioPharma, Inc. shares in Q3 2019, an estimated $174K.
Alberta Investment Management Corp (AIMCo) first reported a position in PDL BioPharma, Inc. in Q3 2016 and held it in 5 quarters.
Alberta Investment Management Corp (AIMCo)'s PDL BioPharma, Inc. position peaked at $610K in Q3 2016.
140 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q3 2019.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q3 2019, filed 23 Oct 2019.